EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Analytical Performance Comparison of Three Quantitative Hepatitis B Surface Antigen Assays

Young Jin Ko, Jared Castor, Trever D Kuralt, Erin A Goecker, Gregory Pepper, Jonathan C Reed, Alexander L Greninger

Clinical Chemistry · 2026

DOI: 10.1093/clinchem/hvaf191 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Chemistry, 2026. Verfasst von Young Jin Ko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Laboratory Medicine, University of Washington, Chosun University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Quantitative hepatitis B surface antigen (qHBsAg) assays are important tools for monitoring hepatitis B virus (HBV) infection and treatment response and constitute the primary endpoint in most HBV antiviral trials. To date, no qHBsAg assay has been authorized by the FDA for use in the United States, highlighting the need for performance evaluation and harmonization of available methods.

Methods

We evaluated the analytical performance of three commercial assays for qHBsAg measurement: Architect HBsAg Qualitative (Abbott) adapted for quantitative use, Elecsys HBsAg II quant II (Roche), and LIAISON XL Murex HBsAg Quant (DiaSorin). Performance characteristics including precision, accuracy, analytical sensitivity, linearity, and lot-to-lot variability were assessed using World Health Organization (WHO) International Standards 12/226 and 03/262, following CLSI guidelines. Clinical accuracy was also evaluated using 72 HBsAg-positive clinical specimens.

Results

The lower limit of quantification was 0.02 IU/mL for Architect, 0.07 IU/mL for Elecsys, and 1.02 IU/mL for LIAISON. The LIAISON exhibited limited linearity and significantly greater variability in samples with high HBsAg levels, as well as significant lot-to-lot variability. Ultimately, all three assays demonstrated acceptable precision and accuracy, though the LIAISON had to be recalibrated specifically with WHO International Standard 03/262.

Conclusions

The Architect and Elecsys qHBsAg assays demonstrated sufficient analytical performance for clinical use, while the LIAISON was limited by its linearity, lower limit of quantification, and lot-to-lot variability. Standardization is essential to ensure consistent and accurate quantification of HBsAg for effective clinical monitoring and the establishment of treatment goals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensHumansHepatitis BImmunoassayReproducibility of ResultsHepatitis B virusLimit of DetectionSensitivity and Specificity

Substanzen

Hepatitis B Surface Antigens

Autor:innen und Institutionen

  • Department of Laboratory Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.

Förderung

  • Department of Laboratory Medicine
  • University of Washington
  • Chosun University

Zitieren

APA

Ko, Y. J., Castor, J., Kuralt, T. D., Goecker, E. A., Pepper, G., Reed, J. C., & Greninger, A. L. (2026). Analytical Performance Comparison of Three Quantitative Hepatitis B Surface Antigen Assays. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvaf191

Vancouver

Ko YJ, Castor J, Kuralt TD, Goecker EA, Pepper G, Reed JC, et al. Analytical Performance Comparison of Three Quantitative Hepatitis B Surface Antigen Assays. Clinical Chemistry. 2026. doi:10.1093/clinchem/hvaf191

BibTeX
@article{Ko2026,
  author = {Ko, Young Jin and Castor, Jared and Kuralt, Trever D and Goecker, Erin A and Pepper, Gregory and Reed, Jonathan C and Greninger, Alexander L},
  title = {Analytical Performance Comparison of Three Quantitative Hepatitis B Surface Antigen Assays},
  journal = {Clinical Chemistry},
  year = {2026},
  doi = {10.1093/clinchem/hvaf191}
}
Kostenlos starten →